Abstract PR05: A novel kinase inhibitor for B-catenin mutant hepatocellular carcinoma
Alexander Rialdi(Icahn School of Medicine at Mount Sinai), Ernesto Guccione(Tisch Hospital), Mary E. Duffy(Tisch Hospital), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Amaia Lujambio(Icahn School of Medicine at Mount Sinai), Alex Scopton(Tisch Hospital)
Cited by 0
Related Papers
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
|Annual Review of Biochemistry|2011|391